APVO — APTEVO THERAPEUTICS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 10 SEC-registered investment managers reported holding APVO (APTEVO THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $272.39K across 61.27K shares. That is -6.2% by share count (-3.33K shares) versus the previous quarter, while reported value moved -2.4%. Ownership is concentrated: the five largest holders account for 98.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 2 opened new positions, 1 added to existing stakes, 2 trimmed, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of APTEVO THERAPEUTICS INC (APVO) include Point72 Asset Management, SABBY MANAGEMENT, LLC, ARMISTICE CAPITAL, LLC, ranked by reported 13F value among the 56 institutional holders on this page.
APVO is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 8 | 290.72K | $529.11K | -0.0% |
| Q2 2026 | 10 | 61.27K | $272.39K | -6.2% |
| Q1 2026 | 9 | 53.75K | $229.65K | +596.6% |
| Q4 2025 | 10 | 20.29K | $191.36K | -76.1% |
| Q3 2025 | 11 | 362.52K | $526.48K | +69.7% |
| Q2 2025 | 7 | 15.04K | $45.86K | -20.1% |
| Q1 2025 | 7 | 16.83K | $19.52K | +21.8% |
| Q4 2024 | 13 | 48.49K | $208.67K | -54.9% |
Over the 8 quarters shown, institutional share counts increased 500% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q1 2026 (+596.6%).
Top Institutional Holders (Q3 2026) — 8 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 232.69K | $423.50K | 9.41% | New | |
| 40.70K | $74.07K | 0.00% | New | |
| 12.71K | $23.14K | 0.00% | Hold | |
| 4.14K | $7.54K | 0.00% | Hold | |
| 360 | $664 | 0.00% | Hold | |
| 105 | $191 | 0.00% | Reduce | |
| 3 | $5 | 0.00% | New | |
| 1 | $2 | 0.00% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 10 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 21.54K | $96.00K | 0.01% | Add | |
| 12.71K | $56.45K | 0.00% | Hold | |
| 10.82K | $48.04K | 0.00% | New | |
| 10.82K | $48.04K | 0.00% | Reduce | |
| 4.14K | $18.39K | 0.00% | Hold | |
| 730 | $3.24K | 0.00% | Reduce | |
| 360 | $1.60K | 0.00% | Hold | |
| 109 | $484 | 0.00% | Hold | |
| 31 | $138 | 0.00% | New | |
| 1 | $4 | 0.00% | Hold |
Q1 2026 — 9 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 19.64K | $84.00K | 0.01% | New | |
| 13.34K | $56.95K | 0.00% | New | |
| 12.71K | $54.28K | 0.00% | New | |
| 4.14K | $17.69K | 0.00% | New | |
| 3.44K | $14.71K | 0.00% | Add | |
| 360 | $1.53K | 0.00% | Hold | |
| 109 | $465 | 0.00% | Add | |
| 5 | $21 | 0.00% | New | |
| 1 | $4 | 0.00% | Hold |
Q4 2025 — 10 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 16.86K | $158.95K | 0.00% | New | |
| 2.76K | $25.99K | 0.00% | Add | |
| 360 | $3.39K | 0.00% | Reduce | |
| 170 | $1.60K | 0.00% | Reduce | |
| 92 | $868 | 0.00% | Reduce | |
| 31 | $292 | 0.00% | Reduce | |
| 13 | $118 | 0.00% | New | |
| 7 | $66 | 0.00% | Reduce | |
| 7 | $66 | 0.00% | New | |
| 1 | $9 | 0.00% | Hold |
Q3 2025 — 11 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 299.94K | $434.92K | 0.00% | New | |
| 38.28K | $56.00K | 0.00% | New | |
| 10.00K | $14.50K | 0.00% | New | |
| 6.50K | $9.76K | 0.00% | Add | |
| 5.67K | $8.23K | 0.00% | New | |
| 1.45K | $2.10K | 0.00% | Add | |
| 570 | $827 | 0.00% | Reduce | |
| 74 | $107 | 0.00% | New | |
| 27 | $39 | 0.00% | Add | |
| 1 | $1 | 0.00% | Hold | |
| 1 | $1 | 0.00% | Hold |
Q2 2025 — 7 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 10.00K | $30.50K | 0.03% | New | |
| 3.25K | $9.91K | 0.00% | Add | |
| 1.19K | $3.64K | 0.00% | Reduce | |
| 588 | $1.79K | 0.00% | Reduce | |
| 3 | $9 | 0.00% | Reduce | |
| 1 | $3 | 0.00% | Reduce | |
| 1 | $3 | 0.00% | New |
New Positions (Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 10.82K sh · $48.04K
- BARCLAYS PLC 31 sh · $138
Fully Exited (vs previous quarter)
- CWM, LLC sold 5 sh · $21
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | 232.69K | — | — | — | — | — | — | — | — | 501.50K | — | 349.47K | 1.33M | — | — | — | — | — | — | — |
| Hudson Bay Capital Management LP | 40.70K | — | — | — | — | — | — | — | 935.55K | 500.00K | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 12.71K | 12.71K | 12.71K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 4.14K | 4.14K | 4.14K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OSAIC HOLDINGS, INC. | 360 | 360 | 360 | 360 | 6.50K | 3.25K | 1 | 1 | 45 | 45 | 45 | 30 | 30 | — | — | — | — | — | — | — |
| SBI Securities Co., Ltd. | 105 | 109 | 109 | 31 | 570 | 588 | 701 | 131 | — | — | — | — | — | — | — | — | — | — | — | — |
| Caitong International Asset Management Co., Ltd | 3 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| DANSKE BANK A/S | 1 | 1 | 1 | 1 | 1 | 1 | — | 1 | — | — | — | — | — | — | — | — | — | — | — | — |
| Renaissance Technologies | — | — | — | — | — | — | — | — | 36.58K | — | — | 516.79K | 175.98K | 80.19K | 54.99K | 65.49K | 68.39K | 69.89K | 58.89K | 68.69K |
| Point72 Asset Management | — | — | — | — | 299.94K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ARMISTICE CAPITAL, LLC | — | — | — | — | — | — | — | — | — | 749.23K | — | 61.13K | 1.24M | — | — | — | — | — | — | — |
| Northern Trust Corp | — | — | — | — | — | — | — | — | — | — | — | 14.12K | 14.12K | 17.64K | 17.64K | 17.34K | 17.52K | 16.94K | 16.70K | 22.56K |
| Vanguard Group | — | — | — | 16.86K | — | — | — | — | — | — | — | 91.72K | 221.06K | 228.82K | 229.36K | 238.98K | 238.84K | 238.84K | 240.82K | 224.48K |
| GSA CAPITAL PARTNERS LLP | — | 21.54K | 19.64K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Virtu Financial LLC | — | — | — | — | 38.28K | — | — | 21.63K | 41.97K | 17.39K | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | — | 10.82K | 13.34K | — | — | — | 10.53K | — | 43.68K | 19.39K | — | 43.20K | 75.36K | 52.83K | 52.83K | 52.83K | 52.96K | 52.96K | 52.73K | 39.81K |
| HRT FINANCIAL LP | — | — | — | — | — | — | — | 12.32K | 28.12K | 30.56K | — | — | — | — | — | — | — | — | — | — |
| GEODE CAPITAL MANAGEMENT, LLC | — | 10.82K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Citadel Advisors | — | — | — | — | — | — | — | — | 111.63K | — | — | 262.12K | — | 12.78K | — | 42.07K | 16.78K | — | — | — |
| Schonfeld Strategic Advisors LLC | — | — | — | — | — | — | — | — | — | — | — | 159.00K | 142.80K | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold APVO?
As of 2026-Q2, 10 institutional funds reported holding APVO (APTEVO THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $272.39K.
How many shares of APVO do institutions own?
13F filers reported 61.27K shares of APVO, worth $272.39K in aggregate at the end of 2026-Q2.
Is institutional ownership of APVO rising or falling?
Share counts moved -6.2% versus the prior quarter — distribution.
Who are the top institutional holders of APVO?
The largest 13F holders are Point72 Asset Management, SABBY MANAGEMENT, LLC, ARMISTICE CAPITAL, LLC, Vanguard Group, GSA CAPITAL PARTNERS LLP; the top 25 are ranked at the top of this page.
Who are the major shareholders of APTEVO THERAPEUTICS INC?
The major shareholders of APTEVO THERAPEUTICS INC (APVO) by reported 13F value are Point72 Asset Management, SABBY MANAGEMENT, LLC, ARMISTICE CAPITAL, LLC, Vanguard Group, GSA CAPITAL PARTNERS LLP, among 56 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.